Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board
2nd Floor, Woodland House, Maes-Y-Coed Rd
Cardiff
CF14 4TT
UK
Ffôn: +44 292136446
E-bost: rhian.lye@wales.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: http://nwssp.nhs.wales/ourservices/procurement-services/
Cyfeiriad proffil y prynwr: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Caffael ar y cyd
Caiff y contract ei ddyfarnu gan gorff prynu canolog
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples
Cyfeirnod: CAV-OJEU-PROJECT45611
II.1.2) Prif god CPV
33696500
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) on behalf of Cardiff and Vale University Health Board are looking to procurement a somatic NGS testing platform with a single workflow for both DNA and RNA library preparation. It must be a targeted panel of at least 500 genes for the DNA component and 50 genes for the RNA component which are of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 10 768 696.40 GBP
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
33696500
II.2.3) Man cyflawni
Cod NUTS:
UKL22
Prif safle neu fan cyflawni:
All Wales Medical Genomics Laboratory
Cardiff & Vale University Health Board
University Hospital of Wales
Heath Park
Cardiff
CF14 4XW
II.2.4) Disgrifiad o’r caffaeliad
The All Wales Medical Genomics Laboratory (AWMGL) recently received an uplift in funding to enable the delivery of equitable testing for patients in Wales to patients in England who are eligible for tests detailed in the Genomics England National Genomics Test Directory for Cancer, thus, supporting AWMGL to work with Welsh clinicians to align services to the Test Directory. To enable successful alignment it is essential that the laboratory expands their services that are offered to those that are indicated as essential services in the Genomics England National Genomics Test Directory for Cancer 2020/2021 (https://www.england.nhs.uk/publication/national-genomic-test-directories/).
To meet the service needs, AWMGL are looking to purchase a new DNA and RNA based single targeted somatic testing panel of at least 500 genes of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).
II.2.5) Meini prawf dyfarnu
Maes prawf ansawdd: Quality
/ Pwysoliad: 60
Price
/ Pwysoliad:
40
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn agored
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2020/S 203-494848
Section V: Dyfarnu contract
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
16/03/2021
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 2
Nifer y tendrau a ddaeth i law gan BBaChau: 0
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau yr UE: 2
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau nad ydynt yn aelodau o'r UE: 0
Nifer y tendrau a ddaeth i law drwy ddulliau electronig: 2
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Illumina Cambridge Ltd
Illumina Centre, 19 Granta Park, Great Abington
Cambridge
CB216DF
UK
Ffôn: +44 1223824908
NUTS: UKH12
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 10 768 696.40 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.
2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.
3. The Contracting Authority will not accept completed ITT's after the stated closing date.
4. All documents to be priced (where applicable) in sterling and all payments made in sterling.
5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.
6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale ULHB
7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_83892 for all tender documentation.
(WA Ref:110589)
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
High Court
Royal Courts of Justice, The Strand
London
UK
VI.4.3) Gweithdrefn adolygu
Gwybodaeth fanwl gywir am y terfyn(au) amser ar gyfer gweithdrefnau adolygu:
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful. Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.
VI.5) Dyddiad anfon yr hysbysiad hwn
12/05/2021